We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Harri Sihto, Ph.D., is a biochemist and an Adjunct Professor in Cancer Biology at the University of Helsinki. Dr. Sihto is a co-founder and Chairman of the Board of Sartar Therapeutics and takes care of the management of the company at the moment. He have over 15 years’ experience of molecular cancer research. His current research has focused on prognostic factors and novel therapeutic targets in rare cancers.
This speaker's sessions: